Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Scientific Games (SGMS) Financials

Scientific Games logo
Annual Income Statements for Scientific Games

Annual Income Statements for Scientific Games

This table shows Scientific Games' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
0.00 -354 -242 -352 -130 -569 371 3,675 163 336
Consolidated Net Income / (Loss)
0.00 -354 -242 -352 -118 -548 390 3,697 180 336
Net Income / (Loss) Continuing Operations
0.00 -354 -242 -352 -330 -801 24 -176 180 336
Total Pre-Tax Income
0.00 -479 -227 -339 -377 -804 -294 -163 205 421
Total Operating Income
0.00 131 394 266 290 -245 110 273 518 668
Total Gross Profit
0.00 1,777 1,920 2,108 1,642 1,089 1,544 1,774 2,030 2,257
Total Revenue
0.00 2,883 3,084 3,363 2,388 1,699 2,153 2,512 2,902 3,188
Operating Revenue
- 2,883 3,084 3,363 2,388 1,699 2,153 2,512 2,902 3,188
Total Cost of Revenue
0.00 1,106 1,164 1,255 746 610 609 738 872 931
Operating Cost of Revenue
- 1,106 1,164 1,255 746 610 609 738 872 931
Total Operating Expenses
0.00 1,647 1,526 1,842 1,352 1,334 1,434 1,501 1,512 1,589
Selling, General & Admin Expense
- 577 613 697 619 627 679 717 808 872
Research & Development Expense
- 205 184 202 166 148 190 218 228 262
Depreciation Expense
- 739 683 690 542 449 398 420 384 361
Restructuring Charge
- 57 46 253 25 56 167 146 92 94
Total Other Income / (Expense), net
0.00 -609 -621 -605 -667 -559 -404 -436 -313 -247
Interest Expense
- 636 648 690 689 504 478 474 324 295
Other Income / (Expense), net
- 14 0.00 60 22 -55 74 38 11 48
Income Tax Expense
- -125 15 13 -47 -3.00 -318 13 25 85
Net Income / (Loss) Discontinued Operations
- - - - 212 253 366 3,873 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
- - 0.00 0.00 12 21 19 22 17 0.00
Basic Earnings per Share
($16.23) ($4.05) ($2.72) ($3.87) ($1.40) ($6.02) $3.86 $38.78 $1.79 $3.77
Weighted Average Basic Shares Outstanding
85.90M 87.30M 89M 91M 93M 95M 96M 95M 91M 89M
Diluted Earnings per Share
($16.23) ($4.05) ($2.72) ($3.87) ($1.40) ($6.02) $3.77 $38.78 $1.75 $3.68
Weighted Average Diluted Shares Outstanding
85.90M 87.30M 89M 91M 93M 95M 98M 95M 93M 91M
Weighted Average Basic & Diluted Shares Outstanding
85.90M 87.30M 89.10M 91.10M 93.87M 95.39M 96.68M 91.00M 89.83M 84.47M

Quarterly Income Statements for Scientific Games

This table shows Scientific Games' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
328 30 22 -1.00 75 67 82 82 64 108
Consolidated Net Income / (Loss)
335 39 27 5.00 80 68 82 82 64 108
Net Income / (Loss) Continuing Operations
20 21 27 5.00 80 68 82 82 64 108
Total Pre-Tax Income
24 26 26 20 94 65 100 108 81 132
Total Operating Income
89 98 102 113 147 156 165 175 159 169
Total Gross Profit
455 477 468 513 513 536 537 582 571 567
Total Revenue
648 682 670 731 731 770 756 818 817 797
Operating Revenue
648 682 670 731 731 770 756 818 817 797
Total Cost of Revenue
193 205 202 218 218 234 219 236 246 230
Operating Cost of Revenue
193 205 202 218 218 234 219 236 246 230
Total Operating Expenses
366 379 366 400 366 380 372 407 412 398
Selling, General & Admin Expense
181 182 192 203 204 209 218 220 220 214
Research & Development Expense
56 53 54 58 55 61 62 66 66 68
Depreciation Expense
102 103 101 108 90 85 86 87 90 98
Restructuring Charge
27 41 19 31 17 25 6.00 34 36 18
Total Other Income / (Expense), net
-65 -72 -76 -93 -53 -91 -65 -67 -78 -37
Interest Expense
68 73 75 78 93 78 75 75 75 70
Other Income / (Expense), net
3.00 1.00 -1.00 -15 40 -13 10 8.00 -3.00 33
Income Tax Expense
4.00 5.00 -1.00 15 14 -3.00 18 26 17 24
Basic Earnings per Share
$3.47 $0.44 $0.24 ($0.01) $0.83 $0.73 $0.91 $0.92 $0.72 $1.22
Weighted Average Basic Shares Outstanding
94M 95M 91M 91M 91M 91M 90M 90M 89M 89M
Diluted Earnings per Share
$3.42 $0.49 $0.23 ($0.01) $0.81 $0.72 $0.88 $0.90 $0.71 $1.19
Weighted Average Diluted Shares Outstanding
96M 95M 93M 91M 92M 93M 92M 92M 91M 91M
Weighted Average Basic & Diluted Shares Outstanding
93.67M 91.00M 91.12M 91.36M 90.05M 89.83M 90.14M 88.72M 88.31M 84.47M

Annual Cash Flow Statements for Scientific Games

This table details how cash moves in and out of Scientific Games' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
- -9.90 677 -614 564 768 -442 266 -446 -209
Net Cash From Operating Activities
- 419 507 346 546 471 685 -381 590 632
Net Cash From Continuing Operating Activities
- 419 507 346 209 33 304 -425 590 632
Net Income / (Loss) Continuing Operations
- -354 -242 -352 94 -801 24 -176 180 336
Consolidated Net Income / (Loss)
- -354 -242 -352 -118 -548 390 3,697 180 336
Net Income / (Loss) Discontinued Operations
- - - - -212 253 366 3,873 0.00 0.00
Depreciation Expense
- 739 683 690 542 449 398 420 384 361
Non-Cash Adjustments To Reconcile Net Income
- 130 93 140 156 291 103 203 155 135
Changes in Operating Assets and Liabilities, net
- -96 -27 -132 -173 94 -221 -872 -129 -200
Net Cash From Discontinued Operating Activities
- - - - 337 438 381 44 0.00 0.00
Net Cash From Investing Activities
- -228 -415 -798 -263 -173 -442 6,116 -251 -258
Net Cash From Continuing Investing Activities
- -228 -415 -798 -220 -126 -347 -252 -248 -258
Purchase of Property, Plant & Equipment
- -273 -294 -391 -224 -137 -171 -216 -242 -294
Acquisitions
- -1.20 -165 -477 0.00 -13 -186 -136 -4.00 -5.00
Sale and/or Maturity of Investments
- - - - - 24 10 50 -2.00 41
Other Investing Activities, net
- 29 44 70 4.00 0.00 0.00 50 0.00 0.00
Net Cash From Discontinued Investing Activities
- - - - -43 -47 -95 6,368 -3.00 0.00
Net Cash From Financing Activities
- -196 580 -156 -129 463 -679 -5,463 -788 -577
Net Cash From Continuing Financing Activities
- -196 580 -156 -126 469 -655 -5,460 -788 -577
Repayment of Debt
- -500 -1,945 -3,162 -3,002 -583 -642 -7,410 -797 -15
Repurchase of Common Equity
- - 0.00 0.00 -9.00 0.00 0.00 -442 -193 -462
Issuance of Debt
- 360 2,587 3,072 2,570 1,080 60 2,480 755 0.00
Other Financing Activities, net
- -56 -62 -66 -27 -32 -73 -88 -553 -100
Net Cash From Discontinued Financing Activities
- - - - -3.00 -6.00 -24 -3.00 0.00 0.00
Effect of Exchange Rate Changes
- -4.90 5.00 - - 7.00 -6.00 -6.00 3.00 -6.00
Cash Interest Paid
- 622 633 633 549 471 453 351 306 286
Cash Income Taxes Paid
- 22 33 33 41 22 38 692 147 164

Quarterly Cash Flow Statements for Scientific Games

This table details how cash moves in and out of Scientific Games' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
304 -359 63 -66 -17 -426 32 -131 -15 -95
Net Cash From Operating Activities
-351 -87 185 34 204 167 171 141 118 202
Net Cash From Continuing Operating Activities
-359 -79 185 34 204 167 171 141 118 202
Net Income / (Loss) Continuing Operations
20 21 27 5.00 80 68 82 82 64 108
Consolidated Net Income / (Loss)
335 39 27 5.00 80 68 82 82 64 108
Non-Cash Adjustments To Reconcile Net Income
119 -285 138 182 72 -237 110 125 76 -176
Changes in Operating Assets and Liabilities, net
-498 -235 20 -153 52 -48 -21 -66 -22 -91
Net Cash From Investing Activities
685 -28 -57 -61 -72 -61 -71 -87 -71 -29
Net Cash From Continuing Investing Activities
-54 -28 -57 -61 -72 -58 -71 -87 -71 -29
Purchase of Property, Plant & Equipment
-58 -58 -53 -59 -70 -60 -66 -87 -71 -70
Other Investing Activities, net
- - -4.00 -2.00 -2.00 8.00 -5.00 - - 5.00
Net Cash From Financing Activities
-24 -250 -65 -40 -146 -537 -65 -185 -65 -262
Net Cash From Continuing Financing Activities
-24 -250 -65 -40 -146 -537 -65 -185 -65 -262
Repayment of Debt
-55 -43 -6.00 -5.00 -576 -210 0.00 -5.00 - -10
Repurchase of Common Equity
-11 -221 -36 3.00 -112 -48 -25 -150 -44 -243
Other Financing Activities, net
-8.00 14 -23 -38 -8.00 -484 -40 -30 -21 -9.00
Effect of Exchange Rate Changes
-6.00 6.00 0.00 1.00 -3.00 5.00 -3.00 - 3.00 -6.00
Cash Interest Paid
52 80 63 84 74 85 63 83 62 78
Cash Income Taxes Paid
474 195 9.00 87 23 28 8.00 62 48 46

Annual Balance Sheets for Scientific Games

This table presents Scientific Games' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets
7,732 - 7,725 7,718 7,809 7,984 7,883 6,009 5,552 5,421
Total Current Assets
1,176 - 1,876 1,369 1,615 2,181 1,732 1,694 1,311 1,183
Cash & Equivalents
129 - 789 168 313 928 585 914 425 196
Restricted Cash
20 - 29 39 51 45 41 47 90 110
Accounts Receivable
487 - 541 599 755 438 423 455 506 585
Inventories, net
249 - 243 216 244 119 98 161 177 158
Prepaid Expenses
123 - 131 233 252 98 88 117 113 134
Plant, Property, & Equipment, net
794 - 568 547 500 242 213 204 236 286
Total Noncurrent Assets
5,763 - 5,281 5,802 5,694 5,561 5,938 4,111 4,005 3,952
Noncurrent Note & Lease Receivables
51 - 53 40 53 19 17 14 37 97
Goodwill
3,014 - 2,956 3,280 3,280 2,730 2,892 2,919 2,945 2,890
Intangible Assets
2,406 - 1,944 2,094 1,774 1,231 1,063 942 763 615
Noncurrent Deferred & Refundable Income Taxes
- - - - - 106 349 114 142 229
Other Noncurrent Operating Assets
45 - 58 77 303 99 131 116 112 115
Other Noncurrent Nonoperating Assets
18 - 16 13 11 1,376 1,486 6.00 6.00 6.00
Total Liabilities & Shareholders' Equity
7,732 - 7,725 7,718 7,809 7,984 7,883 6,009 5,552 5,421
Total Liabilities
9,228 - 9,752 10,181 9,917 10,508 9,989 4,848 4,787 4,785
Total Current Liabilities
654 - 740 747 766 832 974 622 696 735
Short-Term Debt
50 - 40 45 45 44 44 24 22 23
Accounts Payable
160 - 190 225 226 150 204 154 241 216
Accrued Expenses
444 - 509 477 495 343 428 380 404 447
Current Deferred & Payable Income Tax Liabilities
- - - - - - 16 64 29 49
Total Noncurrent Liabilities
8,574 - 9,013 9,434 9,151 9,676 9,015 4,226 4,091 4,050
Long-Term Debt
8,157 - 8,736 8,992 8,680 9,259 8,646 3,870 3,852 3,847
Noncurrent Deferred & Payable Income Tax Liabilities
228 - 73 108 91 46 35 87 20 12
Other Noncurrent Operating Liabilities
189 - 203 334 380 233 210 269 219 191
Commitments & Contingencies
0.00 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-1,496 - -2,027 -2,463 -2,108 -2,524 -2,106 1,161 765 636
Total Preferred & Common Equity
-1,496 - -2,027 -2,463 -2,212 -2,653 -2,256 990 765 636
Total Common Equity
-1,496 - -2,027 -2,463 -2,212 -2,653 -2,256 990 765 636
Common Stock
767 - 809 836 1,209 1,269 1,338 1,371 1,119 1,201
Retained Earnings
-1,865 - -2,461 -2,824 -2,954 -3,529 -3,158 517 680 1,016
Treasury Stock
-175 - -175 -175 -175 -175 -175 -580 -751 -1,216
Accumulated Other Comprehensive Income / (Loss)
-222 - -200 -300 -292 -218 -261 -318 -283 -365

Quarterly Balance Sheets for Scientific Games

This table presents Scientific Games' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets
6,246 6,022 5,962 5,887 5,588 5,538 5,596
Total Current Assets
2,048 1,762 1,735 1,720 1,340 1,289 1,279
Cash & Equivalents
1,277 931 909 891 450 321 347
Restricted Cash
42 93 48 50 97 95 54
Accounts Receivable
426 458 499 477 504 575 580
Inventories, net
137 172 183 183 175 186 183
Prepaid Expenses
166 108 96 119 114 112 115
Plant, Property, & Equipment, net
202 214 214 229 246 269 281
Total Noncurrent Assets
3,996 4,046 4,013 3,938 4,002 3,980 4,036
Noncurrent Note & Lease Receivables
16 14 12 11 57 60 93
Goodwill
2,865 2,922 2,930 2,903 2,925 2,925 2,954
Intangible Assets
897 884 835 789 728 691 662
Noncurrent Deferred & Refundable Income Taxes
92 112 112 112 166 180 215
Other Noncurrent Operating Assets
119 108 117 117 120 118 106
Other Noncurrent Nonoperating Assets
7.00 6.00 7.00 6.00 6.00 6.00 6.00
Total Liabilities & Shareholders' Equity
6,246 6,022 5,962 5,887 5,588 5,538 5,596
Total Liabilities
5,014 4,838 4,732 4,741 4,753 4,752 4,738
Total Current Liabilities
802 642 577 619 677 696 680
Short-Term Debt
24 23 23 22 22 22 23
Accounts Payable
176 189 171 162 211 277 200
Accrued Expenses
352 362 371 403 381 362 429
Current Deferred & Payable Income Tax Liabilities
250 68 12 32 63 35 28
Total Noncurrent Liabilities
4,212 4,196 4,155 4,122 4,076 4,056 4,058
Long-Term Debt
3,874 3,867 3,863 3,855 3,852 3,849 3,850
Noncurrent Deferred & Payable Income Tax Liabilities
143 71 51 43 20 19 20
Other Noncurrent Operating Liabilities
195 258 241 224 204 188 188
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,232 1,184 1,230 1,146 835 786 858
Total Preferred & Common Equity
1,071 1,008 1,048 959 835 786 858
Total Common Equity
1,071 1,008 1,048 959 835 786 858
Common Stock
1,377 1,389 1,388 1,403 1,155 1,176 1,183
Retained Earnings
487 539 538 613 762 844 908
Treasury Stock
-378 -608 -613 -726 -776 -927 -972
Accumulated Other Comprehensive Income / (Loss)
-415 -312 -265 -331 -306 -307 -261

Annual Metrics and Ratios for Scientific Games

This table displays calculated financial ratios and metrics derived from Scientific Games' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
-100.00% 0.00% 6.96% 9.05% -28.99% -28.85% 26.72% 16.67% 15.53% 9.86%
EBITDA Growth
-100.00% 0.00% 21.94% -5.66% -15.94% -82.55% 290.60% 25.60% 24.90% 17.96%
EBIT Growth
100.00% 0.00% 172.66% -17.26% -4.29% -196.15% 161.33% 69.02% 70.10% 35.35%
NOPAT Growth
100.00% 0.00% 201.68% -32.49% 9.02% -184.48% 144.90% 148.18% 138.01% 17.22%
Net Income Growth
100.00% 0.00% 31.58% -45.45% 66.48% -364.41% 171.17% 847.95% -95.13% 86.67%
EPS Growth
-485.92% 75.05% 32.84% -42.28% 63.82% -330.00% 162.62% 928.65% -95.49% 110.29%
Operating Cash Flow Growth
0.00% 0.00% 21.00% -31.76% 57.80% -13.74% 45.44% -155.62% 254.86% 7.12%
Free Cash Flow Firm Growth
130.56% 328.15% -184.05% 96.13% 239.29% 412.93% -99.60% 7,968.33% -12.24% 7.60%
Invested Capital Growth
-19.16% -100.00% 0.00% 6.97% -1.44% -27.79% 1.65% -6.69% 0.73% 1.85%
Revenue Q/Q Growth
-100.00% 2,535.65% 2.36% 1.87% -30.22% 9.83% 36.61% 4.23% 3.13% 0.85%
EBITDA Q/Q Growth
100.00% -20.65% 10.25% 38.87% -39.22% -38.68% 64.87% 10.09% 2.93% 7.16%
EBIT Q/Q Growth
100.00% -87.02% 35.67% 836.78% -58.12% -57.07% 4,500.00% 30.67% 9.07% 8.98%
NOPAT Q/Q Growth
100.00% -91.79% 38.93% 547.20% -68.34% -10.36% 623.81% 52.51% 23.41% -2.66%
Net Income Q/Q Growth
100.00% -134.54% 21.94% 41.61% -189.39% -8.30% 88.41% -1.60% 19.21% 13.51%
EPS Q/Q Growth
-6.22% 5.81% 22.29% 41.63% -204.48% -8.86% 102.69% -1.20% 15.13% 14.64%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 8.99% -27.00% 38.93% 3.52% 10.84% -460.29% 75.60% 5.86%
Free Cash Flow Firm Q/Q Growth
130.04% 189.37% -1,274.09% -256.32% -38.90% 305.76% -99.46% -24.51% 339.99% 52.54%
Invested Capital Q/Q Growth
-10.61% -100.00% -0.75% 4.57% 0.18% -20.71% 1.41% 7.47% 1.03% -3.01%
Profitability Metrics
- - - - - - - - - -
Gross Margin
0.00% 61.63% 62.26% 62.68% 68.76% 64.10% 71.71% 70.62% 69.95% 70.80%
EBITDA Margin
0.00% 30.63% 34.92% 30.21% 35.76% 8.77% 27.03% 29.10% 31.46% 33.78%
Operating Margin
0.00% 4.53% 12.78% 7.91% 12.14% -14.42% 5.11% 10.87% 17.85% 20.95%
EBIT Margin
0.00% 5.01% 12.78% 9.69% 13.07% -17.66% 8.55% 12.38% 18.23% 22.46%
Profit (Net Income) Margin
0.00% -12.27% -7.85% -10.47% -4.94% -32.25% 18.11% 147.17% 6.20% 10.54%
Tax Burden Percent
0.00% 73.89% 106.61% 103.83% 31.30% 68.16% -132.65% -2,268.10% 87.80% 79.81%
Interest Burden Percent
0.00% -331.28% -57.61% -103.99% -120.83% 268.00% -159.78% -52.41% 38.75% 58.80%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 12.20% 20.19%
Return on Invested Capital (ROIC)
0.00% 2.89% 9.74% 3.18% 3.38% -3.34% 1.77% 4.51% 11.09% 12.83%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -8.50% -3.73% -3.46% -0.49% -8.39% 6.47% 79.00% 2.33% 7.12%
Return on Net Nonoperating Assets (RNNOA)
0.00% 44.41% 14.13% 12.50% 1.79% 27.00% -18.62% -786.95% 7.61% 35.14%
Return on Equity (ROE)
0.00% 47.30% 23.88% 15.68% 5.16% 23.66% -16.85% -782.43% 18.69% 47.97%
Cash Return on Invested Capital (CROIC)
21.18% 202.89% -190.26% -3.55% 4.82% 28.94% 0.14% 11.43% 10.35% 11.00%
Operating Return on Assets (OROA)
0.00% 3.74% 10.20% 4.22% 4.02% -3.80% 2.32% 4.48% 9.15% 13.05%
Return on Assets (ROA)
0.00% -9.15% -6.27% -4.56% -1.52% -6.94% 4.92% 53.22% 3.11% 6.12%
Return on Common Equity (ROCE)
0.00% 47.30% 23.88% 15.68% 5.28% 24.85% -17.86% -1,048.21% 17.03% 47.97%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 11.94% 14.29% 5.33% 20.66% -17.29% 373.43% 23.53% 52.83%
Net Operating Profit after Tax (NOPAT)
0.00 91 276 186 203 -172 77 191 455 533
NOPAT Margin
0.00% 3.17% 8.94% 5.54% 8.50% -10.09% 3.58% 7.61% 15.67% 16.72%
Net Nonoperating Expense Percent (NNEP)
0.00% 11.40% 13.47% 6.64% 3.87% 5.05% -4.70% -74.48% 8.75% 5.70%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 3.78% 9.80% 11.83%
Cost of Revenue to Revenue
0.00% 38.37% 37.74% 37.32% 31.24% 35.90% 28.29% 29.38% 30.05% 29.20%
SG&A Expenses to Revenue
0.00% 20.01% 19.88% 20.73% 25.92% 36.90% 31.54% 28.54% 27.84% 27.35%
R&D to Revenue
0.00% 7.10% 5.97% 6.01% 6.95% 8.71% 8.82% 8.68% 7.86% 8.22%
Operating Expenses to Revenue
0.00% 57.10% 49.48% 54.77% 56.62% 78.52% 66.60% 59.75% 52.10% 49.84%
Earnings before Interest and Taxes (EBIT)
0.00 145 394 326 312 -300 184 311 529 716
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
0.00 883 1,077 1,016 854 149 582 731 913 1,077
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.54 9.67 11.99
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 0.43 1.49 0.49 1.05 2.32 3.00 2.19 2.55 2.39
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 17.39 1.49 45.36 22.70
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 5.75% 66.95% 2.20% 4.40%
Enterprise Value to Invested Capital (EV/IC)
1.36 0.00 2.17 1.68 1.79 2.88 3.35 2.10 2.61 2.67
Enterprise Value to Revenue (EV/Rev)
0.00 0.43 3.99 3.02 4.48 7.30 6.81 3.42 3.71 3.51
Enterprise Value to EBITDA (EV/EBITDA)
0.00 1.39 11.42 10.01 12.52 83.27 25.20 11.76 11.78 10.39
Enterprise Value to EBIT (EV/EBIT)
0.00 8.48 31.23 31.20 34.26 0.00 79.70 27.63 20.33 15.63
Enterprise Value to NOPAT (EV/NOPAT)
0.00 13.41 44.61 54.63 52.66 0.00 190.44 44.97 23.64 20.99
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 2.93 24.27 29.40 19.58 26.34 21.41 0.00 18.23 17.71
Enterprise Value to Free Cash Flow (EV/FCFF)
5.75 0.19 0.00 0.00 36.86 8.34 2,443.99 17.75 25.31 24.48
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
-5.49 0.00 -4.33 -3.67 -4.14 -3.69 -4.13 3.35 5.06 6.08
Long-Term Debt to Equity
-5.45 0.00 -4.31 -3.65 -4.12 -3.67 -4.11 3.33 5.04 6.05
Financial Leverage
-10.47 -5.22 -3.79 -3.61 -3.63 -3.22 -2.88 -9.96 3.26 4.93
Leverage Ratio
-11.70 -5.17 -3.81 -3.44 -3.40 -3.41 -3.43 -14.70 6.00 7.83
Compound Leverage Factor
0.00 17.13 2.20 3.58 4.10 -9.14 5.48 7.70 2.33 4.61
Debt to Total Capital
122.28% 0.00% 130.03% 137.47% 131.86% 137.23% 131.99% 77.03% 83.51% 85.89%
Short-Term Debt to Total Capital
0.75% 0.00% 0.60% 0.68% 0.68% 0.65% 0.67% 0.47% 0.47% 0.51%
Long-Term Debt to Total Capital
121.53% 0.00% 129.43% 136.78% 131.18% 136.58% 131.32% 76.56% 83.04% 85.38%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 1.57% 1.90% 2.28% 3.38% 0.00% 0.00%
Common Equity to Total Capital
-22.28% 0.00% -30.03% -37.47% -33.43% -39.14% -34.26% 19.58% 16.49% 14.11%
Debt to EBITDA
0.00 0.00 8.15 8.89 10.22 62.44 14.93 5.33 4.24 3.59
Net Debt to EBITDA
0.00 0.00 7.15 8.40 9.47 55.91 13.86 4.01 3.68 3.31
Long-Term Debt to EBITDA
0.00 0.00 8.11 8.85 10.16 62.14 14.86 5.29 4.22 3.57
Debt to NOPAT
0.00 0.00 31.82 48.53 42.98 -54.24 112.86 20.38 8.52 7.26
Net Debt to NOPAT
0.00 0.00 27.94 45.82 39.84 -48.57 104.73 15.35 7.39 6.69
Long-Term Debt to NOPAT
0.00 0.00 31.68 48.29 42.76 -53.99 112.29 20.25 8.47 7.22
Altman Z-Score
-0.21 0.00 0.58 0.26 0.19 -0.10 0.29 1.60 2.07 2.34
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% -2.28% -5.03% -6.03% -33.97% 8.88% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.80 0.00 2.54 1.83 2.11 2.62 1.78 2.72 1.88 1.61
Quick Ratio
1.20 0.00 1.99 1.18 1.39 1.64 1.03 2.20 1.34 1.06
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,497 6,408 -5,386 -208 290 1,488 6.00 484 425 457
Operating Cash Flow to CapEx
0.00% 163.54% 172.45% 88.49% 243.75% 343.80% 400.58% -176.39% 243.80% 214.97%
Free Cash Flow to Firm to Interest Expense
0.00 10.07 -8.31 -0.30 0.42 2.95 0.01 1.02 1.31 1.55
Operating Cash Flow to Interest Expense
0.00 0.66 0.78 0.50 0.79 0.93 1.43 -0.80 1.82 2.14
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.26 0.33 -0.07 0.47 0.66 1.08 -1.26 1.07 1.15
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.00 0.75 0.80 0.44 0.31 0.22 0.27 0.36 0.50 0.58
Accounts Receivable Turnover
0.00 0.00 0.00 5.90 3.53 2.85 5.00 5.72 6.04 5.84
Inventory Turnover
0.00 0.00 0.00 5.47 3.24 3.36 5.61 5.70 5.16 5.56
Fixed Asset Turnover
0.00 0.00 0.00 6.03 4.56 4.58 9.46 12.05 13.19 12.21
Accounts Payable Turnover
0.00 0.00 0.00 6.04 3.31 3.24 3.44 4.12 4.42 4.07
Days Sales Outstanding (DSO)
0.00 0.00 0.00 61.86 103.48 128.15 72.98 63.79 60.44 62.46
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 66.76 112.53 108.60 65.03 64.05 70.74 65.67
Days Payable Outstanding (DPO)
0.00 0.00 0.00 60.41 110.33 112.49 106.08 88.53 82.67 89.58
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 68.21 105.68 124.26 31.93 39.31 48.51 38.54
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
6,316 0.00 5,662 6,056 5,969 4,310 4,381 4,088 4,118 4,194
Invested Capital Turnover
0.00 0.91 1.09 0.57 0.40 0.33 0.50 0.59 0.71 0.77
Increase / (Decrease) in Invested Capital
-1,497 -6,316 5,662 394 -87 -1,659 71 -293 30 76
Enterprise Value (EV)
8,603 1,226 12,304 10,172 10,689 12,408 14,664 8,593 10,753 11,192
Market Capitalization
773 1,226 4,599 1,640 2,497 3,949 6,450 5,489 7,394 7,628
Book Value per Share
($17.34) $0.00 ($22.61) ($26.86) ($23.72) ($27.88) ($23.38) $10.57 $8.50 $7.20
Tangible Book Value per Share
($80.19) $0.00 ($77.28) ($85.46) ($77.92) ($69.50) ($64.35) ($30.65) ($32.68) ($32.49)
Total Capital
6,712 0.00 6,750 6,574 6,617 6,779 6,584 5,055 4,639 4,506
Total Debt
8,207 0.00 8,777 9,037 8,725 9,303 8,690 3,894 3,874 3,870
Total Long-Term Debt
8,157 0.00 8,736 8,992 8,680 9,259 8,646 3,870 3,852 3,847
Net Debt
7,830 0.00 7,705 8,532 8,088 8,330 8,064 2,933 3,359 3,564
Capital Expenditures (CapEx)
0.00 256 294 391 224 137 171 216 242 294
Debt-free, Cash-free Net Working Capital (DFCFNWC)
423 0.00 359 460 530 420 176 135 122 165
Debt-free Net Working Capital (DFNWC)
572 0.00 1,177 667 894 1,393 802 1,096 637 471
Net Working Capital (NWC)
522 0.00 1,137 622 849 1,349 758 1,072 615 448
Net Nonoperating Expense (NNE)
0.00 445 518 538 321 377 -313 -3,506 275 197
Net Nonoperating Obligations (NNO)
7,812 0.00 7,689 8,519 8,077 6,834 6,487 2,927 3,353 3,558
Total Depreciation and Amortization (D&A)
0.00 739 683 690 542 449 398 420 384 361
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 11.64% 13.68% 22.19% 24.72% 8.17% 5.37% 4.20% 5.18%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 38.16% 19.83% 37.44% 81.99% 37.25% 43.63% 21.95% 14.77%
Net Working Capital to Revenue
0.00% 0.00% 36.85% 18.50% 35.55% 79.40% 35.21% 42.68% 21.19% 14.05%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
($16.23) ($4.05) ($2.72) ($3.87) ($1.40) ($6.02) $3.86 $38.78 $1.79 $3.77
Adjusted Weighted Average Basic Shares Outstanding
85.90M 87.30M 89.10M 91.10M 93M 95M 96M 95M 91M 89M
Adjusted Diluted Earnings per Share
($16.23) ($4.05) ($2.72) ($3.87) ($1.40) ($6.02) $3.77 $38.78 $1.75 $3.68
Adjusted Weighted Average Diluted Shares Outstanding
85.90M 87.30M 89.10M 91.10M 93M 95M 98M 95M 93M 91M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
86.53M 88.13M 89.10M 92.25M 93.87M 95.39M 96.68M 91.00M 89.83M 84.47M
Normalized Net Operating Profit after Tax (NOPAT)
0.00 180 308 363 221 -95 194 293 536 608
Normalized NOPAT Margin
0.00% 6.23% 9.99% 10.80% 9.23% -5.56% 9.01% 11.68% 18.46% 19.08%
Pre Tax Income Margin
0.00% -16.60% -7.36% -10.08% -15.79% -47.32% -13.66% -6.49% 7.06% 13.21%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 0.23 0.61 0.47 0.45 -0.60 0.38 0.66 1.63 2.43
NOPAT to Interest Expense
0.00 0.14 0.43 0.27 0.29 -0.34 0.16 0.40 1.40 1.81
EBIT Less CapEx to Interest Expense
0.00 -0.18 0.15 -0.09 0.13 -0.87 0.03 0.20 0.89 1.43
NOPAT Less CapEx to Interest Expense
0.00 -0.26 -0.03 -0.30 -0.03 -0.61 -0.20 -0.05 0.66 0.81
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% -7.63% 0.00% 0.00% 11.96% 107.22% 137.50%

Quarterly Metrics and Ratios for Scientific Games

This table displays calculated financial ratios and metrics derived from Scientific Games' official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
20.22% 17.59% 17.13% 19.84% 12.81% 12.90% 12.84% 11.90% 11.76% 3.51%
EBITDA Growth
34.72% 49.63% 26.25% 17.71% 42.78% 12.87% 29.21% 31.07% -11.19% 31.58%
EBIT Growth
91.67% 280.77% 94.23% 44.12% 103.26% 44.44% 73.27% 86.73% -16.58% 41.26%
NOPAT Growth
211.62% 2,726.92% 278.30% -12.27% 68.68% 106.18% 27.73% 370.34% 0.42% -15.27%
Net Income Growth
79.14% -60.61% -3.57% -99.85% -76.12% 74.36% 203.70% 1,540.00% -20.00% 58.82%
EPS Growth
85.87% -48.96% -11.54% -100.03% -76.32% 46.94% 282.61% 9,100.00% -12.35% 65.28%
Operating Cash Flow Growth
-287.70% -138.50% 96.81% 191.89% 158.12% 291.95% -7.57% 314.71% -42.16% 20.96%
Free Cash Flow Firm Growth
-48.22% 645.68% -32.55% -134.84% -124.89% -64.21% -95.88% 107.11% 16.69% -53.25%
Invested Capital Growth
-11.94% -6.69% -10.21% 21.33% 7.15% 0.73% 2.77% 2.00% 6.08% 1.85%
Revenue Q/Q Growth
6.23% 5.25% -1.76% 9.10% 0.00% 5.34% -1.82% 8.20% -0.12% -2.45%
EBITDA Q/Q Growth
10.86% 4.12% 0.00% 1.98% 34.47% -17.69% 14.47% 3.45% -8.89% 21.95%
EBIT Q/Q Growth
35.29% 7.61% 2.02% -2.97% 90.82% -23.53% 22.38% 4.57% -14.75% 29.49%
NOPAT Q/Q Growth
130.33% 6.72% 33.82% -73.33% 342.85% 30.45% -17.10% -1.80% -5.45% 10.06%
Net Income Q/Q Growth
-89.83% -88.36% -30.77% -81.48% 1,500.00% -15.00% 20.59% 0.00% -21.95% 68.75%
EPS Q/Q Growth
-90.12% -85.67% -53.06% -104.35% 8,200.00% -11.11% 22.22% 2.27% -21.11% 67.61%
Operating Cash Flow Q/Q Growth
-848.65% 75.21% 312.64% -81.62% 500.00% -18.14% 2.40% -17.54% -16.31% 71.19%
Free Cash Flow Firm Q/Q Growth
-70.70% -36.94% 52.07% -224.00% 79.07% 190.68% -82.51% 114.04% -345.38% 150.89%
Invested Capital Q/Q Growth
11.16% 7.47% -1.08% 2.67% -1.83% 1.03% 0.92% 1.90% 2.10% -3.01%
Profitability Metrics
- - - - - - - - - -
Gross Margin
70.22% 69.94% 69.85% 70.18% 70.18% 69.61% 71.03% 71.15% 69.89% 71.14%
EBITDA Margin
29.94% 29.62% 30.15% 28.18% 37.89% 29.61% 34.52% 33.01% 30.11% 37.64%
Operating Margin
13.73% 14.37% 15.22% 15.46% 20.11% 20.26% 21.83% 21.39% 19.46% 21.20%
EBIT Margin
14.20% 14.52% 15.07% 13.41% 25.58% 18.57% 23.15% 22.37% 19.09% 25.35%
Profit (Net Income) Margin
51.70% 5.72% 4.03% 0.68% 10.94% 8.83% 10.85% 10.02% 7.83% 13.55%
Tax Burden Percent
1,395.83% 150.00% 103.85% 25.00% 85.11% 104.62% 82.00% 75.93% 79.01% 81.82%
Interest Burden Percent
26.09% 26.26% 25.74% 20.41% 50.27% 45.45% 57.14% 59.02% 51.92% 65.35%
Effective Tax Rate
16.67% 19.23% -3.85% 75.00% 14.89% -4.62% 18.00% 24.07% 20.99% 18.18%
Return on Invested Capital (ROIC)
6.79% 6.89% 9.65% 2.79% 12.22% 14.99% 13.04% 11.91% 11.57% 13.31%
ROIC Less NNEP Spread (ROIC-NNEP)
12.53% 6.03% 7.99% 1.92% 10.58% 11.96% 11.32% 10.31% 9.65% 12.43%
Return on Net Nonoperating Assets (RNNOA)
-118.71% -60.09% -79.69% 4.71% 24.49% 38.99% 34.65% 32.59% 30.79% 61.33%
Return on Equity (ROE)
-111.92% -53.20% -70.03% 7.49% 36.71% 53.98% 47.69% 44.51% 42.36% 74.64%
Cash Return on Invested Capital (CROIC)
15.79% 11.43% 16.25% -11.20% 2.45% 10.35% 9.20% 11.06% 7.14% 11.00%
Operating Return on Assets (OROA)
4.85% 5.25% 5.63% 5.88% 11.87% 9.32% 11.92% 11.96% 10.51% 14.73%
Return on Assets (ROA)
17.68% 2.07% 1.51% 0.30% 5.08% 4.43% 5.58% 5.36% 4.31% 7.87%
Return on Common Equity (ROCE)
-147.52% -71.28% -94.14% 6.34% 31.34% 49.19% 43.54% 40.49% 38.41% 74.64%
Return on Equity Simple (ROE_SIMPLE)
350.79% 0.00% 366.67% 38.74% 15.75% 0.00% 28.14% 39.69% 34.50% 0.00%
Net Operating Profit after Tax (NOPAT)
74 79 106 28 125 163 135 133 126 138
NOPAT Margin
11.45% 11.61% 15.81% 3.86% 17.11% 21.19% 17.90% 16.24% 15.38% 17.35%
Net Nonoperating Expense Percent (NNEP)
-5.74% 0.85% 1.66% 0.86% 1.64% 3.03% 1.72% 1.60% 1.93% 0.88%
Return On Investment Capital (ROIC_SIMPLE)
- 1.57% - - - 3.52% - - - 3.07%
Cost of Revenue to Revenue
29.78% 30.06% 30.15% 29.82% 29.82% 30.39% 28.97% 28.85% 30.11% 28.86%
SG&A Expenses to Revenue
27.93% 26.69% 28.66% 27.77% 27.91% 27.14% 28.84% 26.89% 26.93% 26.85%
R&D to Revenue
8.64% 7.77% 8.06% 7.93% 7.52% 7.92% 8.20% 8.07% 8.08% 8.53%
Operating Expenses to Revenue
56.48% 55.57% 54.63% 54.72% 50.07% 49.35% 49.21% 49.76% 50.43% 49.94%
Earnings before Interest and Taxes (EBIT)
92 99 101 98 187 143 175 183 156 202
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
194 202 202 206 277 228 261 270 246 300
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
3.78 5.54 5.42 5.98 6.80 9.67 11.01 12.03 9.38 11.99
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.68 2.19 2.09 2.29 2.32 2.55 3.08 3.07 2.55 2.39
Price to Earnings (P/E)
1.08 1.49 1.49 16.53 51.72 45.36 41.22 30.89 27.29 22.70
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
92.46% 66.95% 67.18% 6.05% 1.93% 2.20% 2.43% 3.24% 3.66% 4.40%
Enterprise Value to Invested Capital (EV/IC)
1.78 2.10 2.10 2.26 2.36 2.61 3.01 3.05 2.66 2.67
Enterprise Value to Revenue (EV/Rev)
2.82 3.42 3.26 3.43 3.43 3.71 4.19 4.20 3.65 3.51
Enterprise Value to EBITDA (EV/EBITDA)
10.22 11.76 11.00 11.66 10.87 11.78 12.88 12.46 11.46 10.39
Enterprise Value to EBIT (EV/EBIT)
28.51 27.63 23.63 24.04 19.88 20.33 20.76 18.76 17.54 15.63
Enterprise Value to NOPAT (EV/NOPAT)
54.15 44.97 36.28 30.67 26.15 23.64 25.58 23.61 21.04 20.99
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 28.69 18.23 21.74 18.90 19.30 17.71
Enterprise Value to Free Cash Flow (EV/FCFF)
10.58 17.75 12.25 0.00 99.83 25.31 33.18 27.84 38.45 24.48
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
3.16 3.35 3.29 3.16 3.38 5.06 4.64 4.92 4.51 6.08
Long-Term Debt to Equity
3.14 3.33 3.27 3.14 3.36 5.04 4.61 4.90 4.49 6.05
Financial Leverage
-9.47 -9.96 -9.97 2.45 2.31 3.26 3.06 3.16 3.19 4.93
Leverage Ratio
-14.70 -14.70 -14.66 5.67 5.10 6.00 5.75 5.70 5.73 7.83
Compound Leverage Factor
-3.83 -3.86 -3.77 1.16 2.56 2.73 3.29 3.37 2.98 5.12
Debt to Total Capital
75.98% 77.03% 76.67% 75.96% 77.18% 83.51% 82.27% 83.12% 81.86% 85.89%
Short-Term Debt to Total Capital
0.47% 0.47% 0.45% 0.45% 0.44% 0.47% 0.47% 0.47% 0.49% 0.51%
Long-Term Debt to Total Capital
75.52% 76.56% 76.21% 75.51% 76.75% 83.04% 81.80% 82.65% 81.38% 85.38%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
3.14% 3.38% 3.47% 3.56% 3.72% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
20.88% 19.58% 19.87% 20.48% 19.09% 16.49% 17.73% 16.88% 18.14% 14.11%
Debt to EBITDA
5.87 5.33 5.03 4.83 4.37 4.24 3.99 3.74 3.85 3.59
Net Debt to EBITDA
3.88 4.01 3.71 3.64 3.31 3.68 3.42 3.33 3.45 3.31
Long-Term Debt to EBITDA
5.83 5.29 5.00 4.80 4.35 4.22 3.96 3.72 3.83 3.57
Debt to NOPAT
31.11 20.38 16.59 12.71 10.52 8.52 7.92 7.08 7.07 7.26
Net Debt to NOPAT
20.58 15.35 12.22 9.58 7.97 7.39 6.80 6.32 6.34 6.69
Long-Term Debt to NOPAT
30.92 20.25 16.49 12.64 10.46 8.47 7.87 7.04 7.03 7.22
Altman Z-Score
1.27 1.49 1.51 1.67 1.78 1.84 2.13 2.20 2.03 2.03
Noncontrolling Interest Sharing Ratio
-31.80% -33.97% -34.42% 15.35% 14.63% 8.88% 8.72% 9.03% 9.33% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
2.55 2.72 2.74 3.01 2.78 1.88 1.98 1.85 1.88 1.61
Quick Ratio
2.12 2.20 2.16 2.44 2.21 1.34 1.41 1.29 1.36 1.06
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
590 372 566 -702 -147 133 23 50 -122 62
Operating Cash Flow to CapEx
-605.17% -150.00% 349.06% 57.63% 291.43% 278.33% 259.09% 162.07% 166.20% 288.57%
Free Cash Flow to Firm to Interest Expense
8.68 5.10 7.55 -9.00 -1.58 1.71 0.31 0.66 -1.63 0.89
Operating Cash Flow to Interest Expense
-5.16 -1.19 2.47 0.44 2.19 2.14 2.28 1.88 1.57 2.89
Operating Cash Flow Less CapEx to Interest Expense
-6.01 -1.99 1.76 -0.32 1.44 1.37 1.40 0.72 0.63 1.89
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.34 0.36 0.37 0.44 0.46 0.50 0.51 0.53 0.55 0.58
Accounts Receivable Turnover
5.73 5.72 5.87 5.98 6.23 6.04 6.21 5.73 5.98 5.84
Inventory Turnover
5.81 5.70 5.47 5.24 5.27 5.16 5.12 4.92 5.11 5.56
Fixed Asset Turnover
11.48 12.05 12.70 13.04 13.06 13.19 12.99 12.73 12.40 12.21
Accounts Payable Turnover
4.10 4.12 4.03 4.88 4.99 4.42 4.45 4.05 5.17 4.07
Days Sales Outstanding (DSO)
63.69 63.79 62.16 61.08 58.56 60.44 58.76 63.74 61.03 62.46
Days Inventory Outstanding (DIO)
62.82 64.05 66.68 69.61 69.28 70.74 71.23 74.25 71.44 65.67
Days Payable Outstanding (DPO)
89.04 88.53 90.55 74.74 73.17 82.67 82.11 90.14 70.66 89.58
Cash Conversion Cycle (CCC)
37.47 39.31 38.30 55.95 54.67 48.51 47.88 47.85 61.81 38.54
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
3,804 4,088 4,044 4,152 4,076 4,118 4,156 4,235 4,324 4,194
Invested Capital Turnover
0.59 0.59 0.61 0.72 0.71 0.71 0.73 0.73 0.75 0.77
Increase / (Decrease) in Invested Capital
-516 -293 -460 730 272 30 112 83 248 76
Enterprise Value (EV)
6,785 8,593 8,506 9,376 9,639 10,753 12,520 12,909 11,522 11,192
Market Capitalization
4,045 5,489 5,464 6,265 6,516 7,394 9,193 9,454 8,050 7,628
Book Value per Share
$11.35 $10.57 $11.08 $11.50 $10.50 $8.50 $9.28 $8.72 $9.67 $7.20
Tangible Book Value per Share
($28.53) ($30.65) ($30.75) ($29.82) ($29.92) ($32.68) ($31.31) ($31.40) ($31.09) ($32.49)
Total Capital
5,130 5,055 5,074 5,116 5,023 4,639 4,709 4,657 4,731 4,506
Total Debt
3,898 3,894 3,890 3,886 3,877 3,874 3,874 3,871 3,873 3,870
Total Long-Term Debt
3,874 3,870 3,867 3,863 3,855 3,852 3,852 3,849 3,850 3,847
Net Debt
2,579 2,933 2,866 2,929 2,936 3,359 3,327 3,455 3,472 3,564
Capital Expenditures (CapEx)
58 58 53 59 70 60 66 87 71 70
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-49 135 119 224 182 122 138 199 221 165
Debt-free Net Working Capital (DFNWC)
1,270 1,096 1,143 1,181 1,123 637 685 615 622 471
Net Working Capital (NWC)
1,246 1,072 1,120 1,158 1,101 615 663 593 599 448
Net Nonoperating Expense (NNE)
-261 40 79 23 45 95 53 51 62 30
Net Nonoperating Obligations (NNO)
2,572 2,927 2,860 2,922 2,930 3,353 3,321 3,449 3,466 3,558
Total Depreciation and Amortization (D&A)
102 103 101 108 90 85 86 87 90 98
Debt-free, Cash-free Net Working Capital to Revenue
-2.03% 5.37% 4.56% 8.20% 6.47% 4.20% 4.62% 6.47% 6.99% 5.18%
Debt-free Net Working Capital to Revenue
52.70% 43.63% 43.79% 43.24% 39.91% 21.95% 22.93% 20.00% 19.68% 14.77%
Net Working Capital to Revenue
51.70% 42.68% 42.91% 42.40% 39.13% 21.19% 22.19% 19.28% 18.95% 14.05%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$3.47 $0.44 $0.24 ($0.01) $0.83 $0.73 $0.91 $0.92 $0.72 $1.22
Adjusted Weighted Average Basic Shares Outstanding
94M 95M 91M 91M 91M 91M 90M 90M 89M 89M
Adjusted Diluted Earnings per Share
$3.42 $0.49 $0.23 ($0.01) $0.81 $0.72 $0.88 $0.90 $0.71 $1.19
Adjusted Weighted Average Diluted Shares Outstanding
96M 95M 93M 91M 92M 93M 92M 92M 91M 91M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
93.67M 91.00M 91.12M 91.36M 90.05M 89.83M 90.14M 88.72M 88.31M 84.47M
Normalized Net Operating Profit after Tax (NOPAT)
97 112 85 101 140 127 140 159 154 153
Normalized NOPAT Margin
14.92% 16.46% 12.64% 13.79% 19.09% 16.45% 18.55% 19.40% 18.86% 19.20%
Pre Tax Income Margin
3.70% 3.81% 3.88% 2.74% 12.86% 8.44% 13.23% 13.20% 9.91% 16.56%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
1.35 1.36 1.35 1.26 2.01 1.83 2.33 2.44 2.08 2.89
NOPAT to Interest Expense
1.09 1.08 1.41 0.36 1.35 2.09 1.80 1.77 1.68 1.98
EBIT Less CapEx to Interest Expense
0.50 0.56 0.64 0.50 1.26 1.06 1.45 1.28 1.13 1.89
NOPAT Less CapEx to Interest Expense
0.24 0.29 0.71 -0.39 0.59 1.32 0.92 0.61 0.73 0.98
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
5.88% 11.96% 11.55% 65.27% 242.38% 107.22% 77.45% 107.37% 90.20% 137.50%

Frequently Asked Questions About Scientific Games' Financials

When does Scientific Games's financial year end?

According to the most recent income statement we have on file, Scientific Games' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Scientific Games' net income changed over the last 9 years?

Scientific Games' net income appears to be on an upward trend, with a most recent value of $336 million in 2024, rising from $0.00 in 2015. The previous period was $180 million in 2023.

What is Scientific Games's operating income?
Scientific Games's total operating income in 2024 was $668 million, based on the following breakdown:
  • Total Gross Profit: $2.26 billion
  • Total Operating Expenses: $1.59 billion
How has Scientific Games revenue changed over the last 9 years?

Over the last 9 years, Scientific Games' total revenue changed from $0.00 in 2015 to $3.19 billion in 2024, a change of 318,800,000,000.0%.

How much debt does Scientific Games have?

Scientific Games' total liabilities were at $4.79 billion at the end of 2024, a 0.0% decrease from 2023, and a 48.1% decrease since 2015.

How much cash does Scientific Games have?

In the past 9 years, Scientific Games' cash and equivalents has ranged from $0.00 in 2016 to $928 million in 2020, and is currently $196 million as of their latest financial filing in 2024.

How has Scientific Games' book value per share changed over the last 9 years?

Over the last 9 years, Scientific Games' book value per share changed from -17.34 in 2015 to 7.20 in 2024, a change of -141.5%.



This page (NASDAQ:SGMS) was last updated on 4/28/2025 by MarketBeat.com Staff
From Our Partners